Allocation of Covid-19 Vaccine in the UK

ALLOCATION OF COVID-19 VACCINE IN THE UK
by (Name)
The Name of the Class (Course)
Professor (Tutor)
The Name of the School (University)
The City and State where it is locatedThe Date

Background
1.1 COVID-19 Global Pandemic
The emergence of coronavirus (COVID-19) has devastated livelihoods and business operations across the globe. Many people changed their living standards as one of the measures to contain the containing the virus. Coronavirus has not only claimed people’s lives in the United Kingdom (UK) but also many nations across the world. There are cases of COVID-19 infection reported each daily globally, with people recovering and some succumbing to the condition. According to the global trend, more than 100 million people have been infected by the virus, with about 71 million recovering and deaths above 2 million (Craxì et al. 2021, p. 187). While these statistics are based on the global trend, the cases in the UK are also not impressive. There are more than 4 million reported cases, with deaths recorded above 127 thousand people (Roope et al. 2020, p. 558). The diseases have devastated many aspects of normal life, especially due to control challenges as the condition is transmitted from infected persons through droplets generated from coughing, sneezing, and exhaling. The UK has established certain measures, such as severe lockdowns, social distancing, and wearing of the mask but the disease is still a major problem.
1.2 The Need of Vaccine
Despite the containment measures proving ineffective from most countries, formulation of the COVID-19 vaccine has drawn the line to control the spread of the virus. The vaccine has been approved by various agencies, including WHO as safe for distribution. Nonetheless since the virus is still in its early stages, the vaccines need an allocation protocol to ensure to ensure that vulnerable individuals are protected against its potential harm. There is a need to establish proper measures that will prioritize individuals who are at higher risk of getting the virus, or play a role in its rapid spread. All the allocation strategies must ensure that the virus-related challenges are minimized. When we consider the movement of elderly and young people, we can say many young people are immobile and act as the main vectors for the disease. While the elderly is at higher risk, they are less immobile and can only contract the disease through young people. Therefore, the distribution and allocation protocols must consider the population composition, including the risks of spreading and contracting the disease. This will ensure that there is an effective formular for distributing the vaccine and allocating to the right people without imposing any dangers to others. The aim of the process must be reducing the virus spread and potential deaths of people who have never been vaccinated (Knoll, and Wonodi, 2021, p. 73). In this paper, we present a comprehensive protocol that ensures proper allocation and distribution processes are followed. The vaccine, although limited in quantity, must be allocated to both young and elderly people because the risks of spread is higher among the young people. While priority may be placed on the elderly, it is e...